BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  High Point Clinical Trials Center Appoints Melanie Fein, M.D., CPI, DABFM as Medical Director

  Dr. Fein received her Doctor of Medicine at the University of Witwatersrand Medical School in Johannesburg, South Africa before completing her Residency in Miami, Florida.

  April 4, 2018

   · 

  3 min read
• Deals

  St. David’s HealthCare acquires The Austin Diagnostic Clinic

  Hospital system aligns with 154 physicians and providers

  April 4, 2018

   · 

  2 min read
• Business

  Kymera Therapeutics Announces Discovery Collaboration with GSK to Advance New Treatment Modality

  Collaboration to Accelerate the Discovery of Protein Degrading Therapeutics

  April 4, 2018

   · 

  3 min read
• Business

  Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes

  Sigilon’s Afibromer technology will be used to encapsulate insulin-producing cells for the potential treatment of type 1 diabetes

  April 4, 2018

   · 

  6 min read
• Deals

  Inception Neuroscience Program Acquired by Roche

  Another successful outcome from a Versant Discovery Engine Launching successor company, Pipeline Therapeutics

  April 4, 2018

   · 

  3 min read
• Lone Star Bio

  New Publication Highlights Significant Impact of DecisionDx-Melanoma Prognostic Test on Clinical Management of Patients with Melanoma

  Prospective, multicenter study recently published in SKIN The Journal of Cutaneous Medicine

  April 4, 2018

   · 

  5 min read
• Business

  NextCure Appoints Kevin N. Heller, M.D., as Chief Medical Officer and Steve Cobourn, CPA, as Chief Financial Officer

  Both are accomplished executives with proven track records in building biopharmaceutical companies.

  April 4, 2018

   · 

  2 min read
• Biotech Beach

  Cidara Therapeutics to Present Rezafungin Data at the European Congress of Clinical Microbiology and Infectious Diseases 2018 Meeting

  Company secures four oral presentations, including three that will highlight new data demonstrating activity of rezafungin against Candida auris and azole-resistant Aspergillus

  April 4, 2018

   · 

  6 min read
• FDA

  U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations

  FDA Priority Review Granted for U.S. New Drug Application

  April 4, 2018

   · 

  9 min read
• Business

  Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies

  Transaction provides potential for further development of novel mAbs while allowing Arsanis to continue to focus its resources on ongoing Phase 2 clinical trial of lead product candidate ASN100

  April 4, 2018

   · 

  6 min read